Why the study?
Does a novel AI-powered imaging biomarker (FRP) based on CCTA radiomic profiling of perivascular fat improve cardiac risk prediction compared to current state-of-the-art methods?
Does a novel AI-powered imaging biomarker (FRP) based on CCTA radiomic profiling of perivascular fat improve cardiac risk prediction compared to current state-of-the-art methods?
A novel AI-derived radiotranscriptomic signature of perivascular fat on CCTA improves cardiac risk prediction beyond current standard methods.
No takes yet. Share an insight, caveat, or question.
May enhance CCTA-based risk stratification; leaves open whether FRP alters management or outcomes in prospective trials.
Oikonomou et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: